Revolution Medicines: Revolution Medicines to Participate in April 2025 Investor Conferences

REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive officer and chairman, will participate in in two upcoming investor conferences.Details of the company's participation are as follows:Needham 24th Annual Virtual Healthcare ConferenceFireside Chat: Monday, April 7 at 2:15 p.m. ETFull story available on Benzinga.com